Skip to main content
SpringerLink
Log in

Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda®) monotherapy

  • Short Communication
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Bajetta E, Catena L, Procopio G, De Dosso S, Bichisao E, Ferrari L, Martinetti A, Platania M, Verzoni E, Formisano B, Bajetta R (2007) Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? Cancer Chemother Pharmacol 59:637–642

    Article  PubMed  CAS  Google Scholar 

  2. Yalcin S, Oyan B, Bayraktar Y (2007) Current medical treatment of pancreatic neuroendocrine tumors. Hepatogastroenterology 54:278–284 (Review)

    PubMed  Google Scholar 

  3. Yao J, Hoff P, Phan T, Hess K (2005) Improved progression free survival (PFS) and rapid sustained decreased perfusion among patients with advanced carcinoid treated with bevacizumab. J Clin Oncol Supp 23(16S):4007 (Abstract)

    Google Scholar 

  4. Strosberg JR, Kvols LK (2007) A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours. Expert Opin Investig Drugs 16:219–224 (Review)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tumor Center ZeTuP St.Gallen and Chur, Rorschacherstrasse 150, CH-9006, St Gallen, Switzerland

    Gregor Fürstenberger & Hans-Jörg Senn

  2. Institute of Radiology RIS, Rorschacherstrasse 150, CH-9006, St Gallen, Switzerland

    Peter Schmid & Ans Duquesne

  3. Institute of Pathology, Kantonsspital St Gallen, Rorschacherstrasse 95, CH-9006, St Gallen, Switzerland

    Maria Ammann

Authors
  1. Gregor Fürstenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ans Duquesne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Ammann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hans-Jörg Senn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Fürstenberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fürstenberger, G., Schmid, P., Duquesne, A. et al. Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda®) monotherapy. Cancer Chemother Pharmacol 61, 347–348 (2008). https://doi.org/10.1007/s00280-007-0590-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-007-0590-9

Keywords

Search

Navigation